Compare LIQT & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LIQT | IRIX |
|---|---|---|
| Founded | 2004 | 1989 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.3M | 20.2M |
| IPO Year | N/A | 1996 |
| Metric | LIQT | IRIX |
|---|---|---|
| Price | $1.75 | $1.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.20 | N/A |
| AVG Volume (30 Days) | 18.7K | ★ 108.4K |
| Earning Date | 11-13-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $16,788,295.00 | ★ $50,647,000.00 |
| Revenue This Year | $29.90 | $9.61 |
| Revenue Next Year | $17.74 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 10.97 | 4.58 |
| 52 Week Low | $1.34 | $0.78 |
| 52 Week High | $3.35 | $1.72 |
| Indicator | LIQT | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 48.09 | 66.65 |
| Support Level | $1.72 | $1.22 |
| Resistance Level | $1.91 | $1.54 |
| Average True Range (ATR) | 0.10 | 0.10 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 65.96 | 75.32 |
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.